Transition Metal‐Based Therapies for Inflammatory Diseases
Advanced Materials · 2023-09 · 35 (39)
DOI: 10.1002/adma.202212102 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Materials, online erschienen am 02.08.2023. Verfasst von Yilin Song und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Shenyang Pharmaceutical University, Shenyang, Liaoning, 110016, China. Hauptthemen laut MEDLINE: Nanostructures, Transition Elements. Die Arbeit wurde bisher 48-mal zitiert (Crossref) und nennt 252 Literaturangaben.
Abstract (Originalsprache)
Inflammatory disease (ID) is a general term that covers all diseases in which chronic inflammation performs as the major manifestation of pathogenesis. Traditional therapies based on the anti‐inflammatory and immunosuppressive drugs are palliative with the short‐term remission. The emergence of nanodrugs has been reported to solve the potential causes and prevent recurrences, thus holding great potential for the treatment of IDs. Among various nanomaterial systems, transition metal‐based smart nanosystems (TMSNs) with unique electronic structures possess therapeutic advantages owing to their large surface area to volume ratio, high photothermal conversion efficiency, X‐ray absorption capacity, and multiple catalytic enzyme activities. In this review, the rationale, design principle, and therapeutic mechanisms of TMSNs for treatments of various IDs are summarized. Specifically, TMSNs can not only be designed to scavenge danger signals, such as reactive oxygen and nitrogen species and cell‐free DNA, but also can be engineered to block the mechanism of initiating inflammatory responses. In addition, TMSNs can be further applied as nanocarriers to deliver anti‐inflammatory drugs. Finally, the opportunities and challenges of TMSNs are discussed, and the future directions of TMSN‐based ID treatment for clinical applications are emphasized.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Shenyang Pharmaceutical University, Shenyang, Liaoning, 110016, China.
- Departments of Diagnostic, Radiology Surgery, Chemical and Biomolecular Engineering, and Biomedical Engineering, Yong Loo Lin School of Medicine and Faculty of Engineering, National University of Singapore, Singapore, 1…
- Nanomedicine Translational Research Program NUS center for Nanomedicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 117597, Singapore.
- Clinical Imaging Research Centre, Centre for Translational Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 117599, Singapore.
- Institute of Molecular and Cell Biology, Agency for Science, Technology, and Research (A*STAR), 61 Biopolis Drive, Proteos, Singapore, 138673, Singapore.
ORCID-Profile: Xiaoyuan Chen
Zitieren
APA
Song, Y., You, Q., & Chen, X. (2023). Transition Metal‐Based Therapies for Inflammatory Diseases. Advanced Materials, 35(39). https://doi.org/10.1002/adma.202212102
Vancouver
Song Y, You Q, Chen X. Transition Metal‐Based Therapies for Inflammatory Diseases. Advanced Materials. 2023;35(39). doi:10.1002/adma.202212102
BibTeX
@article{Song2023,
author = {Song, Yilin and You, Qing and Chen, Xiaoyuan},
title = {Transition Metal‐Based Therapies for Inflammatory Diseases},
journal = {Advanced Materials},
year = {2023},
volume = {35},
number = {39},
doi = {10.1002/adma.202212102}
}
EUVIMED